Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Harvard Medical School, Boston, MA, USA.
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2914-2924. doi: 10.1007/s00259-021-05206-5. Epub 2021 Feb 9.
To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes.
Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT (n = 77) and postprocedural MRI (n = 56). Local tumor progression was assessed on all available follow-up imaging (1-49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors.
Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05; P = 0.004] for minimum ablation margins < 5 mm.
Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.
本研究旨在通过 FDG PET/CT 引导下微波或冷冻消融术中的术中 PET/CT 图像,回顾性评估肝肿瘤消融边界,并将最小边界测量值与局部进展结果相关联。
56 例(年龄 36-85 岁,中位年龄 62 岁;32 例女性)共 77 个 FDG 摄取肝肿瘤患者行 60 例 FDG PET/CT 引导下经皮微波或冷冻消融术。单屏呼吸 PET/CT 图像用于术中评估肿瘤消融边界:消融后即刻 PET 上肝肿瘤仍可见;微波消融区可见对比增强 CT;冷冻消融区(冰球)可见未增强 CT。两位读者回顾性评估了消融边界的可评估性,并测量了术中 PET/CT(n = 77)和术后 MRI(n = 56)的最小消融边界。所有可获得的随访影像(1-49 个月,平均 15 个月)均评估局部肿瘤进展。使用聚类生存模型对 61 个肿瘤的局部肿瘤进展与 PET/CT 最小边界测量值进行了相关性分析。
术中 PET/CT 评估的最小消融边界(≥77 个肿瘤中的 73 个,95%)比术后 MRI(≤56 个肿瘤中的 35 个,63%)更常见。在 61 个具有可评估 PET/CT 边界的肿瘤(不包括 PET/CT 后重叠消融的肿瘤)中,最小消融边界<5mm 时,局部肿瘤进展的风险增加 6 倍[风险比(HR)6.05;P = 0.004]。
在 FDG 摄取肝肿瘤的 PET/CT 引导下微波或冷冻消融术中,屏气 PET/CT 扫描可可靠地评估整个肿瘤消融边界;最小 PET/CT 消融边界阈值为 5mm 与局部肿瘤进展结果相关性良好。